TrialJournal of endocrinological investigation2024

Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial.

A Dei Cas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.